SMARCB1 and childhood malignant neoplasm: Specifically, almost all malignant rhabdoid tumors (MRTs) and ATRTs, which are highly aggressive childhood cancers without effective therapy, contain biallelic inactivating mutations in the SMARCB1 (SNF5, INI1, BAF47) subunit2,3.